FDA Inspection
Istituto Biochimico Italiano Giovanni Lorenzini S.p.A.Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. – FDA Inspection, Nov 21, 2024
Record Details
This FDA Inspection record concerns Istituto Biochimico Italiano Giovanni Lorenzini S.p.A., with an inspection on November 21, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- November 21, 2024
- Product Type
- Human Drugs
View Company Profile
ID · 1e8711dc-f739-44bb-8418-da1acbab80b2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1254712
- FDA center
- Human Drugs
- Project area
- Postmarketing Surveillance and Epidemiology: Human Drugs
FDA Citations
1- 21 CFR 314.81(b)(2)Timely submission
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Istituto Biochimico Italiano Giovanni Lorenzini S.p.A.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 17, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 4, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 3, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Istituto Biochimico Italiano Giovanni Lorenzini S.p.A.
- FDA Inspection 1235389 - 2023-09-19
- FDA Inspection 1148007 - 2020-02-21
- FDA Inspection 1059331 - 2018-07-17
- FDA Inspection 1017293 - 2017-07-04
- FDA Inspection 919376 - 2015-03-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.